Pathways of Fos expression in locus ceruleus, dorsal vagal complex, and PVN in response to intestinal lipid

H. Monnikes, G. Lauer, C. Bauer, J. Tebbe, T. T. Zittel and R. Arnold Department of Internal Medicine, Philipps-University of Marburg, Germany. Exogenous cholecystokinin (CCK) injected peripherally mimics effects of lipid entering the intestine on food intake and gastric motility via vagal afferents...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of physiology. Regulatory, integrative and comparative physiology Vol. 273; no. 6; pp. 2059 - R2071
Main Authors Monnikes, H, Lauer, G, Bauer, C, Tebbe, J, Zittel, T.T, Arnold, R
Format Journal Article
LanguageEnglish
Published United States 01.12.1997
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:H. Monnikes, G. Lauer, C. Bauer, J. Tebbe, T. T. Zittel and R. Arnold Department of Internal Medicine, Philipps-University of Marburg, Germany. Exogenous cholecystokinin (CCK) injected peripherally mimics effects of lipid entering the intestine on food intake and gastric motility via vagal afferents and induces c-fos expression in the locus ceruleus complex (LCC), nucleus of the solitary tract (NTS), area postrema (AP), and paraventricular nucleus (PVN). However, the role of peripheral endogenous CCK in induction of c-fos expression in the brain at ingestion of nutrients is controversial. In awake rats, intraduodenal lipid infusion markedly increased Fos protein-like immunoreactivity (FLI) in these brain nuclei. Perivagal capsaicin pretreatment reduced the increase of FLI in the LCC, NTS, and PVN by 66-86% and in the AP by 46%. The CCK-A receptor antagonist MK-329 (0.1 mg/kg i.p.) diminished the FLI increase in LC, NTS, AP, and PVN by 39-100%; the CCK-B receptor antagonist L-365,260 reduced the increased FLI in the AP by 54%. After capsaicin pretreatment, both CCK antagonists had additional inhibitory effects only on FLI in the AP. These findings suggest that entry of lipid into the intestine activates c-fos in the LCC, NTS, and PVN predominantly via CCK-A receptors on vagal afferents and in the AP via vagal and nonvagal pathways, as well as CCK-B and CCK-A receptors.
Bibliography:S20
1997072547
ISSN:0002-9513
0363-6119
2163-5773
1522-1490
DOI:10.1152/ajpregu.1997.273.6.r2059